Biotechnology News

January 3, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc., a world leader in the development of best-in-class therapies targeting metalloenzymes, announced today that Robert Schotzinger, M.D., Ph.D., President and CEO of Viamet...

January 3, 2013

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive...

January 3, 2013

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix drug/device test identifies Alzheimer’s disease via beta amyloid signature in the eyes in a 10-subject proof-of-concept clinical trial

January 3, 2013

LOS ALTOS, Calif.--(BUSINESS WIRE)--CardioLogical Solutions formed by the merger of Emboline and VasoStitch

January 3, 2013

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NeoChord receives CE marking for DS1000 mitral valve repair device and plans first enrollments in TACT Registry for Q1 2013

January 3, 2013

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has rescheduled its previously planned...

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Museum of Science is featuring MC10’s virtually invisible, conformal electronics technology as part of its Invented Here! program on Sundays at 12:30 in January.

January 3, 2013

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Reaches Interim Analysis Point of Phase 3 Head and Neck Cancer Study of Lymphoseek®: Company to conduct planned interim analysis of available clinical data

January 3, 2013

CARLSBAD, Calif. & NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Biotech Showcase™ 2013 investor and partnering conference will welcome some of the sector’s most innovative biotech companies to San Francisco on January 7–9. The event will be...

January 3, 2013

BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that the paper "Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias with Bucindolol..." was published in Circulation.

January 3, 2013

FRANKLIN, Tenn.--(BUSINESS WIRE)--BMTI today announced it initiated enrollment in a Phase II clinical trial to assess the safety and efficacy of Augment™ Chronic Tendinopathy (ACT) for tennis elbow.

January 3, 2013

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2013...

January 3, 2013

ANN ARBOR, Mich.--(BUSINESS WIRE)--Truven Health Analytics Projects 4.8 Percent Cost Growth for Health Plans in 2013

January 3, 2013

SAN FRANCISCO--(BUSINESS WIRE)--CollabRx will be presenting at OneMedForum in San Francisco on Wednesday, Jan 9. CollabRx is a data analytics company that uses cloud-based expert systems to inform health care decision making.

January 3, 2013

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has entered into a new agreement with FUJIFILM RI...

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, today announced that...

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive...

January 3, 2013

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, has named Daniel Levitt, M.D., Ph.D., to the newly created position of Executive Vice President. Dr....

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a leader in the development of potentially transformative one-time gene therapies for severe genetic diseases, announced today that Nick Leschly, chief bluebird, is scheduled to present at the 31st...

January 3, 2013

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Dicerna), a RNA interference (RNAi) company focused on developing breakthrough oncology therapeutics, today announced that Kyowa Hakko Kirin Co., Ltd. (KHK) (TSE: 4151) has elected...

January 3, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the 2012 fourth quarter and full year before the market opens on Thursday,...

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases will be presenting at the JPMorgan Healthcare conference on Jan. 9, 2013 at 4:30 PM PST

January 3, 2013

SAN DIEGO--(BUSINESS WIRE)--Tensys receives US FDA 510(k) notification for next generation non-invasive hemodynamic monitoring system.

January 3, 2013

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed CEO David Fineman to present powerful industry use cases for KineMed’s unique systems biology platform in personalized medicine and drug development at Biotech Showcase 2013

January 3, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco Wednesday, January 9, 2013 at 9:00 a.m. PT. The presentation will be available as a...

January 3, 2013

LEIDEN, The Netherlands--(BUSINESS WIRE)--Prosensa, the private Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today announced that Hans Schikan, Chief Executive Officer, will be...

January 3, 2013

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, chairman and chief executive officer...

January 3, 2013

PALO ALTO, Calif. & DEERFIELD, Ill.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced that the J-code assigned by the Centers for Medicare and Medicaid Services (CMS) for OMONTYS® (...

January 3, 2013

SAN FRANCISCO--(BUSINESS WIRE)--Celtaxsys has initiated a first-in-human Phase 1 clinical trial of its oral drug candidate for the treatment of chronic inflammatory disorders, such as cystic fibrosis.

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory...

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present at East/West CEO and J.P. Morgan Healthcare Conferences.

January 3, 2013

HANOI, Vietnam & FORT COLLINS, Colo.--(BUSINESS WIRE)--Inviragen is licensing to VABIOTECH rights to proprietary Japanese encephalitis (JE) technology to produce a cell-derived JE vaccine that VABIOTECH will develop for Vietnam, Cambodia and...

January 3, 2013

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) and Forest Laboratories Holdings, Ltd. (collectively, "Forest") announced today that they have entered into a settlement agreement with Glenmark Generics Inc., USA, Glenmark...

January 3, 2013

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) reported top-line results of EMPOWER, a Phase 3 trial investigating dexpramipexole in people with amyotrophic lateral sclerosis (ALS). The trial did not meet its primary endpoint, a...

January 3, 2013

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (OTCBB: XXII) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the N-methylputrescine oxidase (MPO) gene technology.

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus initiated the 2nd of 2 Phase 2 clinical studies with Z160, calcium channel blocker for the potential treatment of chronic neuropathic pain

January 3, 2013

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis appoints Daniel J. O'Connor Senior Vice President, Chief Legal and Business Development Officer

January 3, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen executes on strategy to outlicense orphan drug program for spinal muscular atrophy; $70 million agreement with Pfizer

January 3, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that it has commenced a $80 million...

January 3, 2013

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: The US-based customer has chosen Precise Biometrics as their new fingerprint algorithm vendor following a thorough test of the market. Precise Biometrics’ solution for embedded systems, which...

January 3, 2013

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted...

January 3, 2013

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 12/823,007, titled “Heterocyclic Compounds for the...

January 3, 2013

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced positive topline results from a phase 1 study of its new antipsychotic candidate, ALKS 3831, a combination of a proprietary drug molecule, ALKS 33, and olanzapine, a molecule...

January 3, 2013

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm announced that President and Chief Executive Officer, Igor Gonda, will present at Biotech Showcase 2013 on Wed, January 9, 2013, at 11 a.m. PT.

January 3, 2013

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Biotech ShowcaseTM 2013 Conference

January 3, 2013

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Ophthotech to Present at 31st Annual J.P. Morgan Healthcare Conference

January 3, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company’s presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco, California on Thursday, January 10, 2013....

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today congratulates Robert S. Langer, ScD,...

January 3, 2013

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics completed a normal healthy volunteer dose escalation trial of its T-type calcium channel inhibitor mibefradil to evaluate PK and confirm safe dose levels for a Phase 1b cancer trial.